RecruitingNot ApplicableNCT06575140

Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery

Pilot Randomized Controlled Trial Assessing Associative Peripheral Stimulation (APS) for Reduction of Motor Impairment During Acute Period of Stroke Recovery

Sponsor

Ahmed A. Rahim

Enrollment

20 participants

Start Date

Dec 18, 2021

Study Type

INTERVENTIONAL

Conditions

Hemiparesis Stroke, Ischemic Stroke Upper Extremity Paresis Stroke, Acute Stroke Sequelae Stroke Hemorrhagic Hemiparesis;Poststroke/CVA Weakness of Extremities as Sequela of Stroke

Summary

Associative Peripheral Stimulation (APS) is a non-invasive therapy intended for stroke rehabilitation involving transcutaneous electrical muscle stimulation paired with voluntary movement. This pilot study investigates whether APS applied during the acute phase of stroke recovery may reduce impairment and improve function in the affected upper extremity.

Eligibility

Min Age: 18 YearsMax Age: 79 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Associative Peripheral Stimulation (APS) 1.0 and a medical device called Peripheral Neuromuscular Stimulation for people with hemiparesis, hemiparesis;poststroke/cva, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 79 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.